Rachel A. Foot

Pulmonary Medicine

200 Albert Sabin Way
Cincinnati, OH 45267

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

Journal: The Lancet. Infectious diseases

Published: April 05, 2026

NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline.

NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline.

Journal: JCI insight

Published: October 14, 2016

Showing 1-2 of 2

Last Updated: 09/26/2026